APRINOIA Therapeutics
Suzhou, China· Est.
APRINOIA Therapeutics is a clinical-stage biotechnology company developing novel therapeutics and diagnostics for neurodegenerative diseases such as Alzheimer's and Parkinson's.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
APRINOIA Therapeutics is a clinical-stage biotechnology company developing novel therapeutics and diagnostics for neurodegenerative diseases such as Alzheimer's and Parkinson's.
NeuroscienceDiagnosticsSmall Molecules